Table 3 The biomarker levels in the two categories (HS/NHS) of patients
| Whole Series |
Healthy stomach (HS Group) n = 22 |
Non-healthy stomach (NHS Group) n = 43 | (p-value)# | |
|---|---|---|---|---|
| aG17b pmol/l mean ± SD (range) |
3.9 ± 5.0 (0–28.1) |
2.05 ± 2.2 (0–9.9) |
4.9 ± 5.7 (0–28.1) | 0.028 |
| bG17 s pmol/l mean ± SD (range) |
12.3 ± 10.3 (0–40.9) |
8.8 ± 8.4 (0.2–36.1) |
14.1 ± 10.8 (0–40.9) | 0.048 |
| PG I μg/I mean ± SD (range) |
81.8 ± 38.6 (22.7–197.5) |
58.2 ± 27.9 (33.0–151.1) |
93.9 ± 38.0 (22.7–197.5) | < 0.0001 |
| PG II μg/I mean ± SD (range) |
7.2 ± 5.9 (0.3–29.3) |
3.37 ± 1.7 (0.3–8.4) |
9.2 ± 6.4 (1.4–29.3) | < 0.0001 |
| PG I/PG II mean ± SD (range) |
15.5 ± 12.3 (3.3–103.3) |
21.6 ± 18.9 (10.7–103.3) |
12.4 ± 4.6 (3.2–25.2) | < 0.0001 |
| IgG EIU mean ± SD (range) |
64.2 ± 40.8 (2.1–121.1) |
13.12 ± 7.7 (2.1–27.3) |
90.4 ± 21.1 (38.1–121.1) | < 0.0001 |